Amyloid-bèta (25-35) [131602-53-4]
A4849
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAmyloid-bèta (25-35) [131602-53-4]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionEndogenous APP peptide cleavage product, primary component in amyloid plaques typical of Alzheimer’s disease.; Amyloid-beta protein fragment (25-35)
- UNSPSC12352200
References
- Hu J, el-Fakahany EE. Neuroreport. 4(6):760-762 (1993).Jia J, Kang L, Li S, et al. Amelioratory effects of testosterone treatment on cognitive performance deficits induced by soluble Abèta1-42 oligomers injected into the hippocampus. Horm Behav. 2013 Aug;64(3):477-86. PMID: 23954394. Yin YI, Bassit B, Zhu L, et al. gamma-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: Implications for Alzheimer Disease. J Biol Chem. 2007 Aug 10;282(32):23639-44. PMID: 17556361. Hartmann T, Bieger SC, Brühl B, et al. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med. 1997 Sep;3(9):1016-20. PMID: 9288729.